PhD Paul Kirkman
At Lubrizol, specialty chemicals expertise enhances practically every facet of life, from the way you move from place to place, to how you take care of yourself, to how you work. Half the vehicles on the planet rely on Lubrizol technology, and half the consumers in the world use at least one product containing Lubrizol technology. In his talk Research Chemist Paul Kirkman will introduce the role of QCM-D in supporting their mission to improve lives around the world.
Professor Ralf Richter
University of Leeds
Professor Ralf Richter is an Associate Professor at University of Leeds. He is aiming to understand the mechanisms of assembly and function of soft biological interfaces. Resolving how these systems work provides new approaches to prevention, diagnosis and treat disease, and inspiration for the design of new functional materials. He took his Master of Science in Physics at Chalmers University of Technology with the Master's Thesis Project on QSense. So when it comes to QCM-D technology, he knows his way.
Dr Fredrik Andersson
Want to know more about the role of QCM-D in research and development? We know who to listen to. Fredrik Andersson is a Scientist and Project leader for Global R&D at Nouryon, with a PhD in Biochemistry from the University of Gothenburg and wide experience in QSense applications. In his lecture The Quartz Crystal Microbalance with Dissipation Method as an Effective Screening Tool in Surface Science Application Development he will explore the possibilities of QCM-D in R&D.
Professor Barbara Jachimska
Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences
Barbara Jachimska is a Professor at Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences in Krakow. Amongst her research topics you can find characteristics and stability of colloidal and bio-colloidal systems. Sounds interesting? We think so too.
Dr Sivashankar Krishnamoorthy
Luxembourg Institute of Science and Technology
Dr Sivashankar Krishnamoorthy has 15 years of experience in development of advanced nanotechnologies. The interest of his research group centers around fabrication and investigation of nanometer scale structures, engineering properties based on rational design principles, and their exploitation within functional devices, materials and interfaces. Developing successful nanotechnologies for biomedical applications is currently in focus. Hear him tell the story.
Dr Gustav Emilsson
Dr Gustav Emilsson at AstraZeneca is working with a novel extended release and liver protecting coating of drug nanocrystals providing prolonged exposure of drug following intravenous administration. How he does it? Using QCM-D.